CAS 1030769-75-5

SRI 37892

CAS : 1030769-75-5

SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability.

Formule : C₂₆H₁₉N₅O₂S

Degré de pureté : 99.93%

Couleur et forme : Solid

Masse moléculaire : 465.53

Ref: TM-T9662

SRI 37892

CAS : 1030769-75-5

SRI 37892

Degré de pureté : ≥98%

Masse moléculaire : 465.53g/mol

Ref: 54-BUP07634

4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide

Produit contrôlé

CAS : 1030769-75-5

4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide (AQBT) is a potent and selective inhibitor of ion channels. AQBT has a high affinity for Na+ currents in the CNS and peripheral nervous system of rats. It is a potent blocker of α7 nicotinic acetylcholine receptors. This compound also inhibits the activity of the neuronal γ amino butyric acid type A receptor (GABAAR).

Formule : C₂₆H₁₉N₅O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 465.5 g/mol

Ref: 3D-FRB76975